TW201400094A - Method for preparing artificial skin dressing with antibacterial and hemostatic functions - Google Patents

Method for preparing artificial skin dressing with antibacterial and hemostatic functions Download PDF

Info

Publication number
TW201400094A
TW201400094A TW101121736A TW101121736A TW201400094A TW 201400094 A TW201400094 A TW 201400094A TW 101121736 A TW101121736 A TW 101121736A TW 101121736 A TW101121736 A TW 101121736A TW 201400094 A TW201400094 A TW 201400094A
Authority
TW
Taiwan
Prior art keywords
artificial skin
skin dressing
polysaccharide
group
antibacterial
Prior art date
Application number
TW101121736A
Other languages
Chinese (zh)
Other versions
TWI458470B (en
Inventor
Shen Cherng
Original Assignee
Shen Cherng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shen Cherng filed Critical Shen Cherng
Priority to TW101121736A priority Critical patent/TWI458470B/en
Publication of TW201400094A publication Critical patent/TW201400094A/en
Application granted granted Critical
Publication of TWI458470B publication Critical patent/TWI458470B/en

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The invention relates to a method for preparing an artificial skin dressing with antibacterial and hemostatic functions. Firstly, a first excipient, a nanosilver porous composite material and a first polysaccharide are mixed, heated and stirred until the first polysaccharide is completely dissolved, to form a substrate. Secondly, the substrate is pressed and coated on a soft plastic board by means of a filter screen as well as filtered out the moisture therein to eventually form a dry substrate film with a certain thickness. Continuously, a second excipient, a natural colloid and a second polysaccharide are mixed, heated and stirred until the second polysaccharide is completely dissolved, to form a shell material. Then the shell material is pressed and coated on the surface of the substrate film by means of a filter screen as well as filtered out the moisture therein. Accordingly, it can not only inhibit the growing and breeding of bacteria and microorganisms on the artificial skin dressing but also promote a blood coagulation reaction for acceleration of wound healing.

Description

抗菌止血人工皮膚敷料製備方法Antibacterial hemostasis artificial skin dressing preparation method

  本發明係有關於一種抗菌止血人工皮膚敷料製備方法,尤其是指一種可同時具有抑制人工皮膚敷料上細菌及微生物的生長和繁殖以及促進血液凝固反應功效者。The invention relates to a method for preparing an antibacterial hemostatic artificial skin dressing, in particular to a method capable of simultaneously inhibiting the growth and reproduction of bacteria and microorganisms on an artificial skin dressing and promoting blood coagulation reaction.

  按,皮膚為人體最大的組織結構,不僅具有體溫調節以及調節體內水分平衡的功能,更是人體防禦外界病原入侵的第一道防線;而當皮膚大面積受傷時,可能會造成身體功能失衡,臟器嚴重失調,甚至因而死亡;一般來說,皮膚傷口經藥物處理後,仍會與衣物或是外界接觸,不小心即可能會因受到碰撞或沾染空氣中的灰塵或細菌,而導致傷口惡化的情形,因此為了要避免傷口暴露於空氣中,人們通常會在處理過的傷口上覆蓋或包紮一經過殺菌處理的人工皮膚敷料做隔絕。According to the skin, the skin is the largest tissue structure of the human body. It not only has the function of regulating body temperature and regulating the water balance in the body, but also the first line of defense against the invasion of external pathogens. When the skin is injured in a large area, it may cause imbalance of body function. Organs are seriously dysfunctional and even die; in general, skin wounds are still in contact with clothing or the outside world after being treated with drugs. If they are accidentally caught, they may be damaged by dust or bacteria in the air. In this case, in order to avoid exposure of the wound to the air, it is common to cover or wrap a treated artificial skin dressing on the treated wound for isolation.

  目前醫療機構對人體外部創傷之治療,如割傷、擦傷、外科手術切口、潰瘍或燒傷等,通常均必須在該等創傷處敷蓋或包紮經滅菌之人工皮膚敷料,以防止為外界細菌所感染;然,一般醫療機構所習用之人工皮膚敷料均需經常換藥,絕大部份仍為紗布或二層紗布間夾棉花經滅菌所製成之棉墊,使用時,敷蓋或包紮於傷口上,其對於淺層創傷,雖有吸收傷口滲液之功效,惟其仍會有滲液回滲腐蝕傷口周圍皮膚,因而造成感染,亦或是吸收之滲液易於揮發而使紗布變硬因而傷害傷口等缺失,實有設法解決之必要。At present, the treatment of external trauma of the human body, such as cuts, abrasions, surgical incisions, ulcers or burns, is usually required to cover or wrap the sterilized artificial skin dressings at the wounds to prevent external bacteria. Infection; however, the artificial skin dressings used in general medical institutions need to be changed frequently. Most of them are cotton pads made by sterilizing cotton between gauze or two layers of gauze. When used, they are covered or wrapped. On the wound, although it has the effect of absorbing the exudate of the wound for the shallow wound, it still has the exudation oozing to corrode the skin around the wound, thus causing infection, or the absorbed exudate is easy to volatilize and the gauze becomes hard. Loss of wounds and other defects, there is a need to find a solution.

  為改善敷料易被微生物或細菌感染之問題,目前市面上已有使用無機銀系列抗菌劑(例如:銀離子)來當作抗菌敷料的原料,以抑制細菌之生長和繁殖,達到減少傷口感染的機會;其原理係因銀離子可以作用在細菌之細胞壁上使細胞壁無法複製,亦可破壞細胞呼吸鏈,阻斷細胞能源供應,甚至直接作用在去氧核醣核酸(DNA)或核醣核酸(RNA)使細胞無法繁殖等特性;惟,含銀敷料其銀離子釋出量不易控制,且一般認為銀離子對於生物體會使DNA失去複製蛋白質的能力,同時也會與蛋白質上的某些官能基形成鍵結,因而使蛋白質受損,因此當銀離子釋出量達到一定程度後,會產生對人體健康造成危害的疑慮;再者,假如傷口不能癒合,亦容易造成細菌或病毒感染,而引起嚴重的後果,如蜂窩性組織炎或致命的敗血症;為了加速傷口的癒合,促進血液凝固反應,以減低傷口的感染,在人工皮膚敷料的功效上亦有必要加以改善。In order to improve the problem that the dressing is easily infected by microorganisms or bacteria, inorganic silver series antibacterial agents (for example, silver ions) have been used as raw materials for antibacterial dressings to inhibit the growth and reproduction of bacteria and reduce wound infection. Opportunity; the principle is that silver ions can act on the cell wall of bacteria to make the cell wall unable to replicate, can also destroy the cellular respiratory chain, block the energy supply of cells, and even directly act on DNA or ribonucleic acid (RNA). Characteristics that make cells unable to multiply; however, silver-containing dressings are difficult to control the release of silver ions, and it is generally believed that silver ions can cause DNA to lose the ability to replicate proteins and also form bonds with certain functional groups on proteins. The knot, thus causing damage to the protein, so when the release amount of silver ions reaches a certain level, there will be doubts that cause harm to human health; in addition, if the wound cannot heal, it is also likely to cause bacterial or viral infection, which causes serious Consequences such as cellulitis or fatal sepsis; in order to accelerate the wound Together, promote blood coagulation reaction, to reduce wound infection, the efficacy of artificial skin in the dressing also need to be improved.

  今,發明人即是鑑於上述現有之人工皮膚敷料相關產品在實際實施上仍具有多處之缺失,於是乃一本孜孜不倦之精神,並藉由其豐富之專業知識及多年之實務經驗所輔佐,而加以改善,並據此研創出本發明。Nowadays, the inventor is still in the spirit of tirelessness in view of the above-mentioned existing artificial skin dressing related products, and is supported by its rich professional knowledge and years of practical experience. Improvements have been made, and the present invention has been developed based on this.

  本發明主要目的為提供一種可同時具有抑制人工皮膚敷料上細菌及微生物的生長和繁殖以及促進血液凝固反應功效之抗菌止血人工皮膚敷料製備方法。The main object of the present invention is to provide an antibacterial hemostatic artificial skin dressing preparation method which can simultaneously inhibit the growth and reproduction of bacteria and microorganisms on artificial skin dressings and promote the blood coagulation reaction.

  為了達到上述實施目的,本發明人乃研擬如下實施技術,首先將一第一賦型劑、一奈米銀多孔性複合材以及一第一多醣體混合,加熱並持續攪拌直到第一多醣體完全溶解,成為人工皮膚敷料之基材;接著,以濾網版加壓塗佈方式將基材均勻網印於塑膠軟板(例如:PE板)上,並使水分完全除去,形成一乾燥且具有特定厚度之基材薄膜;然後,將一第二賦型劑、一天然膠體、以及一第二多醣體混合,加熱並持續攪拌直到第二多醣體完全溶解,成為人工皮膚敷料之殼材;最後,將殼材形成於基材薄膜之表面,並加熱以除去所有水分,形成一具抗菌止血人工皮膚敷料,該人工皮膚敷料係具有基材及殼材混合之雙層薄膜。In order to achieve the above-mentioned purposes, the inventors have developed the following implementation techniques, first mixing a first excipient, a nano-silver porous composite, and a first polysaccharide, heating and stirring until the first The saccharide is completely dissolved and becomes the substrate of the artificial skin dressing; then, the substrate is uniformly screen printed on the plastic soft board (for example, PE board) by the screen printing method, and the moisture is completely removed to form a a substrate film that is dried and has a specific thickness; then, a second excipient, a natural colloid, and a second polysaccharide are mixed, heated and continuously stirred until the second polysaccharide is completely dissolved, thereby becoming an artificial skin dressing Finally, the shell material is formed on the surface of the substrate film and heated to remove all moisture to form an antibacterial hemostatic artificial skin dressing having a two-layer film in which the substrate and the shell material are mixed.

  如上所述的抗菌止血人工皮膚敷料製備方法,其中第一賦型劑與第二賦型劑可分別選自澱粉、甘露醇、乳糖、山梨醇以及聚乙二醇所組成之族群;較佳地,第一、二賦型劑皆選自山梨醇。The antibacterial hemostatic artificial skin dressing preparation method as described above, wherein the first excipient and the second excipient are respectively selected from the group consisting of starch, mannitol, lactose, sorbitol and polyethylene glycol; preferably The first and second excipients are all selected from the group consisting of sorbitol.

  如上所述的抗菌止血人工皮膚敷料製備方法,其中第一多醣體係具有羧基之官能基;較佳地,第一多醣體係為褐藻酸鈉。The antibacterial hemostatic artificial skin dressing preparation method as described above, wherein the first polysaccharide system has a functional group of a carboxyl group; preferably, the first polysaccharide system is sodium alginate.

  如上所述的抗菌止血人工皮膚敷料製備方法,其中第二多醣體係具有胺基之官能基;較佳地,第二多醣體係為幾丁聚醣。The antibacterial hemostatic artificial skin dressing preparation method as described above, wherein the second polysaccharide system has an amine group functional group; preferably, the second polysaccharide system is chitosan.

  如上所述的抗菌止血人工皮膚敷料製備方法,其中天然膠體可選自藻膠、膠原蛋白、明膠以及果膠所組成之族群。The antibacterial hemostatic artificial skin dressing preparation method as described above, wherein the natural colloid may be selected from the group consisting of algin, collagen, gelatin and pectin.

  如上所述的抗菌止血人工皮膚敷料製備方法,其中於製備人工皮膚敷料之基材時,可進一步加入一保濕劑,保濕劑係選自山梨醇、玻尿酸原液、植物性甘油、維他命B5、尿囊素、尿素以及其等之混合物所組成之族群;藉此,以保持創傷面濕度,進而減少傷口疼痛,加速創傷面上皮的癒合。The antibacterial hemostatic artificial skin dressing preparation method as described above, wherein when preparing the artificial skin dressing substrate, a moisturizing agent may be further added, the moisturizing agent is selected from the group consisting of sorbitol, hyaluronic acid stock solution, vegetable glycerin, vitamin B5, and allantoin capsule. a group of elements, urea, and mixtures thereof; thereby maintaining wound surface moisture, thereby reducing wound pain and accelerating wound healing.

  如上所述的抗菌止血人工皮膚敷料製備方法,其中於製備人工皮膚敷料之基材時,可進一步加入一增稠劑,而增稠劑可選自褐藻酸、聚麩胺酸、聚乙烯醇、幾丁聚醣以及其等之混合物所組成之族群。The antibacterial hemostatic artificial skin dressing preparation method as described above, wherein when the artificial skin dressing substrate is prepared, a thickener may be further added, and the thickener may be selected from the group consisting of alginic acid, polyglutamic acid, polyvinyl alcohol, A group of chitosan and a mixture thereof.

  藉此,利用褐藻酸鈉與奈米銀多孔性複合材混合所形成的抗菌基材,以及明膠與幾丁聚醣混合所形成的止血殼材,使得本發明同時具有抗菌與止血之功效,不僅可抑制敷料上細菌及微生物的生長和繁殖,達到減少傷口感染的機會,亦可促進血液凝固反應,以加速傷口的癒合,進而減低傷口感染的機會。Thereby, the antibacterial substrate formed by mixing the sodium alginate and the nano silver porous composite material, and the hemostatic shell material formed by mixing the gelatin and the chitosan make the invention have the effects of antibacterial and hemostasis simultaneously. It can inhibit the growth and reproduction of bacteria and microorganisms on the dressing, reduce the chance of wound infection, and promote blood coagulation reaction to accelerate the healing of wounds, thus reducing the chance of wound infection.

  此外,本發明利用濾網版加壓塗佈網印的方式,將人工皮膚敷料的基材均勻網印於塑膠軟板上,以形成具有抗菌修復功能之基材薄膜,使得敷料薄而柔軟適合於傷口覆蓋,再藉由奈米銀多孔性複合材隔離外界細菌,而褐藻酸鈉則用以促進傷口新生組織的再生,達到抗感染及促進傷口癒合速度,進而減少換藥的次數。In addition, the invention utilizes the screen printing method to apply the screen printing method, and uniformly prints the substrate of the artificial skin dressing on the plastic soft board to form a substrate film having an antibacterial repair function, so that the dressing is thin and soft. In the wound coverage, the nano-silver porous composite material is used to isolate the external bacteria, and the sodium alginate is used to promote the regeneration of wound new tissue, to achieve anti-infection and promote wound healing speed, thereby reducing the number of dressing changes.

  本發明之目的及其結構功能上的優點,將依據以下圖面所示之結構,配合具體實施例予以說明,俾使審查委員能對本發明有更深入且具體之瞭解。
  首先,請參照第一圖所示,為本發明 抗菌止血人工皮膚敷料製備方法其較佳實施例的步驟流程圖,其包括下述步驟:
The object of the present invention and its structural and functional advantages will be explained in conjunction with the specific embodiments according to the structure shown in the following drawings, so that the reviewing committee can have a more in-depth and specific understanding of the present invention.
First, please refer to the first figure, which is a flow chart of a preferred embodiment of a method for preparing an antibacterial hemostatic artificial skin dressing of the present invention, which comprises the following steps:

  步驟一(S1):將一第一賦型劑、一奈米銀多孔性複合材以及一第一多醣體混合,加熱並持續攪拌直到第一多醣體完全溶解,成為人工皮膚敷料之基材;其中,第一多醣體係具有羧基(carboxyl)之官能基,較佳地,第一多醣體係為褐藻酸鈉(alginate),其中褐藻酸(alginic acid)係由褐海藻中得到之不溶性膠體酸,為一群含有不同比例之D-甘露糖醛酸(D-mannuronic acid)及L-古羅糖醛酸(L-guluronic acid)聚合物,這些糖醛酸以α-1﹐4及β-1﹐4鍵結成線形聚合物,分子量約為240﹐000,鈉鹽可溶於水,鈣鹽不溶於水;值得注意的,上述奈米銀多孔性複合材之製備方法係適用於本案申請人於101年4月16日申請之中華民國發明專利(申請號第101113509號)所揭露者,該案『具奈米銀之多孔性抗菌複合材料的製備方法』之內容係作為本案之參考資料;Step 1 (S1): mixing a first excipient, a nano-silver porous composite and a first polysaccharide, heating and stirring until the first polysaccharide is completely dissolved, and becomes the basis of the artificial skin dressing. Wherein the first polysaccharide system has a carboxyl group functional group, preferably, the first polysaccharide system is alginate, wherein the alginic acid is insoluble from brown seaweed Colloidal acid, a group of polymers containing different proportions of D-mannuronic acid and L-guluronic acid, such as α-1, 4 and β -1,4 bond into a linear polymer, molecular weight of about 240,000, sodium salt is soluble in water, calcium salt is insoluble in water; note that the preparation method of the above nano silver porous composite is suitable for the application The person applied for the invention patent of the Republic of China on April 16, 101 (application number) No. 101113509), the content of the "preparation method of porous antibacterial composite material with nano silver" is used as a reference material in the present case;

  步驟二(S2):以濾網版加壓塗佈方式將基材均勻網印於塑膠軟板上,並使水分完全除去,形成一乾燥且具有特定厚度之基材薄膜;其中,濾網版加壓塗佈網印方式係將基材塗佈於特殊大小之濾網,再於適當壓力下網印於塑膠軟板(例如:PE板)上;Step 2 (S2): uniformly coating the substrate on the plastic soft board by screen coating, and completely removing the water to form a dry and specific thickness substrate film; wherein, the screen version The pressure coating screen printing method is to apply the substrate to a special size filter screen, and then screen printing on a plastic soft board (for example, a PE board) under appropriate pressure;

  步驟三(S3):將一第二賦型劑、一天然膠體、以及一第二多醣體混合,加熱並持續攪拌直到第二多醣體完全溶解,成為人工皮膚敷料之殼材;其中,第二多醣體係具有胺基(amine)之官能基,較佳地,第二多醣體係為幾丁聚醣(chitosan);再者,天然膠體可選自藻膠(align)、膠原蛋白(collagen)、明膠(gelatin)以及果膠(pectin)所組成之族群,較佳地,天然膠體係選自明膠;以及Step 3 (S3): mixing a second excipient, a natural colloid, and a second polysaccharide, heating and stirring until the second polysaccharide is completely dissolved, and becomes a shell material of the artificial skin dressing; The second polysaccharide system has a functional group of an amine. Preferably, the second polysaccharide system is chitosan; further, the natural colloid may be selected from the group consisting of aligning and collagen ( a population consisting of collagen, gelatin, and pectin, preferably, the natural gum system is selected from the group consisting of gelatin;

  步驟四(S4):將殼材形成於基材薄膜之表面,並加熱以除去所有水分,形成一具抗菌止血人工皮膚敷料,該人工皮膚敷料係具有基材及殼材混合雙層薄膜。Step 4 (S4): forming a shell material on the surface of the substrate film and heating to remove all moisture to form an antibacterial hemostatic artificial skin dressing having a mixed double layer film of the substrate and the shell material.

  其中,第一賦型劑與第二賦型劑可分別選自澱粉、甘露醇(mannitol)、乳糖(lactose)、山梨醇(sorbitol)以及聚乙二醇(polyethylene glycol,PEG)所組成之族群;較佳地,第一、二賦型劑皆選自山梨醇。Wherein, the first excipient and the second excipient are respectively selected from the group consisting of starch, mannitol, lactose, sorbitol, and polyethylene glycol (PEG). Preferably, the first and second excipients are all selected from the group consisting of sorbitol.

  此外,於上述步驟一(S1)進行時,可進一步加入一保濕劑,保濕劑係選自山梨醇、玻尿酸原液、植物性甘油(vegetable glycerin)、維他命B5、尿囊素(allantoin)、尿素(urea)以及其等之混合物所組成之族群。In addition, in the above step (S1), a moisturizing agent may be further added, and the moisturizing agent is selected from the group consisting of sorbitol, hyaluronic acid stock solution, vegetable glycerin, vitamin B5, allantoin, urea ( Urea) and the group of its mixture.

  再者,亦可於上述步驟一(S1)進行時,進一步加入一增稠劑,而增稠劑可選自褐藻酸(alginic acid)、聚麩胺酸(poly(γ-glutamic acid))、聚乙烯醇(polyvinyl alcohol)、幾丁聚醣以及其等之混合物所組成之族群。Further, when the first step (S1) is performed, a thickener may be further added, and the thickener may be selected from the group consisting of alginate, poly(gamma-glutamic acid), A group consisting of polyvinyl alcohol, chitosan, and mixtures thereof.

  此外,藉由下述實際實施例,可進一步證明本發明之製程可實際應用之範圍,但不意欲以任何形式限制本發明之範圍:In addition, the scope of the invention may be further demonstrated by the following practical embodiments, but is not intended to limit the scope of the invention in any way:

  首先,取20g的硝酸銀晶體溶於80g的去離子水,配置成重量百分比20%的硝酸銀溶液;再取37﹒8mL的硝酸銀溶液溶於500mL的去離子水,製得溶液A;接著,將10g的明膠溶於300mL的去離子水,並將溫度保持在攝氏40度,持續攪拌使明膠溶解均勻;然後,將溶液A倒入並持續攪拌以製得溶液B;取0﹒2g硼氫化鈉溶於100mL去離子水,並加入溶液B,以使溶液B中之銀離子可還原成為銀粒子,製得溶液C,而其銀離子可還原成為銀粒子之化學反應式如下:First, 20 g of silver nitrate crystals were dissolved in 80 g of deionized water and placed in a 20% by weight silver nitrate solution; then 37.8 mL of silver nitrate solution was dissolved in 500 mL of deionized water to prepare a solution A; then, 10 g was obtained. The gelatin is dissolved in 300 mL of deionized water, and the temperature is maintained at 40 ° C. Stirring is continued to dissolve the gelatin uniformly; then, the solution A is poured and continuously stirred to prepare a solution B; 0.2 g of sodium borohydride is dissolved. In 100 mL of deionized water, and adding Solution B, the silver ions in Solution B can be reduced to silver particles to prepare Solution C, and the chemical reaction formula of the silver ions which can be reduced to silver particles is as follows:

  接著,將以氫氧化鈉製成之鹼液滴入溶液C,調整溶液C之pH至6,並將溫度保持在攝氏40度,以製得溶液D;然後,取40g的矽酸鈉溶於500mL去離子水,攪拌使其溶解均勻,製得鹼性溶液E;將10mL的鹽酸加入300ml去離子水配製成為一酸液,製得溶液F;將溶液F快速倒入溶液E中,快速攪拌使得溶液pH值迅速下降至約1﹒5,製得強酸性溶液G;接著,將溶液G緩慢滴入以氫氧化鈉配置而成之鹼液,使其pH值調整為6,製得弱酸性溶液H;最後,再將溶液D快速倒入溶液H中,混合即得到銀-氧化矽錯合物之奈米銀多孔性複合材,亦即銀粒子可被包覆於多孔性之氧化矽矽膠結構中。 Next, the alkali made of sodium hydroxide is dropped into the solution C, the pH of the solution C is adjusted to 6, and the temperature is maintained at 40 degrees Celsius to prepare the solution D; then, 40 g of sodium citrate is dissolved. 500mL deionized water, stirred to dissolve evenly, to obtain an alkaline solution E; 10mL of hydrochloric acid was added to 300ml of deionized water to prepare an acid solution to prepare a solution F; the solution F was quickly poured into the solution E, and rapidly stirred The pH of the solution is rapidly lowered to about 1.5 to prepare a strongly acidic solution G. Then, the solution G is slowly dropped into the alkali solution prepared by using sodium hydroxide to adjust the pH to 6 to obtain a weak acidity. Solution H; finally, the solution D is quickly poured into the solution H, and mixed to obtain a nano-silver porous composite of silver-yttria complex, that is, the silver particles can be coated on the porous cerium oxide rubber. In the structure.

  接著,取8g的去離子水與2g的山梨醇溶液均勻混合,並加入上述0﹒01g的奈米銀多孔性複合材,利用超音波振盪使其均勻分散,再添加褐藻酸鈉1g,加熱至100℃並持續攪拌,直到完全溶解均勻,配置出含銀量3000ppm人工皮膚敷料的基材;接續,以特殊大小及厚度之濾網將殼材基材於適當之壓力(例如1﹒5atm)下網印於塑膠軟板上,加熱至80℃並維持1小時,使水分完全除去,形成具有抗菌修復功能之基材薄膜;值得注意的,濾網網格之大小係決定基材薄膜之厚度,通常網格之孔隙度可為100μm~500μm之間。Next, 8 g of deionized water and 2 g of sorbitol solution were uniformly mixed, and 0.01 g of the nano silver porous composite material was added thereto, and uniformly dispersed by ultrasonic vibration, and then 1 g of sodium alginate was added thereto, and heated to 100 ° C and continuous stirring until completely dissolved, configure a substrate containing 3000 ppm of artificial skin dressing; followed by a special size and thickness of the filter substrate to the appropriate substrate (for example, 1.5 atm) The screen is printed on a plastic soft board and heated to 80 ° C for 1 hour to completely remove the moisture to form a substrate film with antibacterial repair function; it is worth noting that the size of the mesh grid determines the thickness of the substrate film. Generally, the porosity of the mesh may be between 100 μm and 500 μm.

  然後,另取2g的去離子水與1g的山梨醇溶液均勻混合,再添加1g的明膠與0﹒1g的幾丁聚醣,加熱至60℃並持續攪拌,直到幾丁聚醣完全溶解均勻,以做為人工皮膚敷料之殼材;最後,將殼材恆溫於60℃,以特殊大小及厚度之濾網將殼材塗佈,並在適當之壓力(例如1﹒5atm)下網印形成於基材薄膜表面;藉此,使基材薄膜亦具有止血功效,加熱至80℃維持1小時,除去所有的水分,即製備成具有止血抗菌修復功能之人工皮膚敷料,使得本發明之人工皮膚敷料係具有基材及殼材混合雙層薄膜。Then, another 2 g of deionized water and 1 g of sorbitol solution are uniformly mixed, and then 1 g of gelatin and 0.1 g of chitosan are added, and the mixture is heated to 60 ° C and continuously stirred until the chitosan is completely dissolved. As a shell material for artificial skin dressings; finally, the shell material is thermostated at 60 ° C, the shell material is coated with a special size and thickness of the screen, and screen printed under appropriate pressure (for example, 1.5 atm) The surface of the substrate film; thereby, the substrate film also has a hemostatic effect, and is heated to 80 ° C for 1 hour to remove all moisture, thereby preparing an artificial skin dressing having a hemostatic antibacterial repair function, so that the artificial skin dressing of the present invention The invention has a double-layer film mixed with a substrate and a shell material.

  由上述之抗菌止血人工皮膚敷料製備方法與實施說明可知,本發明具有以下優點:It can be seen from the above preparation method and implementation description of the antibacterial hemostatic artificial skin dressing that the present invention has the following advantages:

  1. 本發明藉由褐藻酸鈉與奈米銀多孔性複合材混合所形成的抗菌基材,以及明膠與幾丁聚醣混合所形成的止血殼材,使得本發明同時具有抗菌與止血之功效,不僅可抑制敷料上細菌及微生物的生長和繁殖,達到減少傷口感染的機會,亦可促進血液凝固反應,以加速傷口的癒合,進而減低傷口感染的機會。The antibacterial substrate formed by mixing sodium alginate and nano silver porous composite material, and the hemostatic shell material formed by mixing gelatin and chitosan make the invention have antibacterial and hemostasis effects simultaneously. It can inhibit the growth and reproduction of bacteria and microorganisms on the dressing, reduce the chance of wound infection, and promote blood coagulation reaction to accelerate the healing of wounds, thus reducing the chance of wound infection.
  2. 本發明利用濾網版加壓塗佈網印的方式,將人工皮膚敷料的基材均勻形成於塑膠軟板上,以形成具有抗菌修復功能之基材薄膜,使得敷料薄而柔軟適合於傷口覆蓋,再藉由奈米銀多孔性複合材隔離外界細菌,而褐藻酸鈉則用以促進傷口新生組織的再生,達到抗感染及促進傷口癒合速度,進而減少換藥的次數,而濾網版加壓塗佈網印之方式不同於傳統之浸漬法(dipping)、噴霧法或板刮方式等,使得本發明可準確地控制薄膜之厚度。The invention utilizes the method of screen coating by pressure screen printing to uniformly form the substrate of the artificial skin dressing on the plastic soft board to form a substrate film with antibacterial repair function, so that the dressing is thin and soft and suitable for wound covering. Then, the nano-silver porous composite material is used to isolate the external bacteria, and the sodium alginate is used to promote the regeneration of the wound new tissue, to achieve the anti-infection and promote the wound healing speed, thereby reducing the number of dressing changes, and the screen plate is pressurized. The method of coating the screen printing is different from the conventional dipping method, the spraying method or the plate scraping method, etc., so that the present invention can accurately control the thickness of the film.
  3. 本發明之抗菌止血人工皮膚敷料製備方法可藉由保濕劑的添加,以保持創傷面濕度,進而減少傷口疼痛,加速創傷面上皮的癒合。The preparation method of the antibacterial hemostasis artificial skin dressing of the invention can maintain the wound surface moisture by the addition of the moisturizing agent, thereby reducing the wound pain and accelerating the healing of the wound surface.

  綜上所述,本發明之抗菌止血人工皮膚敷料製備方法,的確能藉由上述所揭露之實施例,達到所預期之使用功效,且本發明亦未曾公開於申請前,誠已完全符合專利法之規定與要求。爰依法提出發明專利之申請,懇請惠予審查,並賜准專利,則實感德便。In summary, the preparation method of the antibacterial hemostasis artificial skin dressing of the present invention can achieve the intended use effect by the above disclosed embodiments, and the present invention has not been disclosed before the application, and has completely complied with the patent law. Regulations and requirements.爰Issuing an application for a patent for invention in accordance with the law, and asking for a review, and granting a patent, is truly sensible.

  惟,上述所揭之圖示及說明,僅為本發明之較佳實施例,非為限定本發明之保護範圍;大凡熟悉該項技藝之人士,其所依本發明之特徵範疇,所作之其它等效變化或修飾,皆應視為不脫離本發明之設計範疇。The illustrations and descriptions of the present invention are merely preferred embodiments of the present invention, and are not intended to limit the scope of the present invention; those skilled in the art, which are characterized by the scope of the present invention, Equivalent variations or modifications are considered to be within the scope of the design of the invention.

(S1)...步驟一(S1). . . step one

(S2)...步驟二(S2). . . Step two

(S3)...步驟三(S3). . . Step three

(S4)...步驟四(S4). . . Step four

第一圖:本發明之製備方法步驟流程圖First Figure: Flow chart of the preparation method of the present invention

(S1)...步驟一(S1). . . step one

(S2)...步驟二(S2). . . Step two

(S3)...步驟三(S3). . . Step three

(S4)...步驟四(S4). . . Step four

Claims (10)

ㄧ種抗菌止血人工皮膚敷料製備方法,係包括有下述步驟:
  步驟一:將一第一賦型劑、一奈米銀多孔性複合材以及一第一多醣體混合,加熱並持續攪拌直到該第一多醣體完全溶解,成為人工皮膚敷料之基材;
  步驟二:以濾網版加壓塗佈方式將該基材均勻網印於塑膠軟板上,並使水分完全除去,形成一乾燥且具有特定厚度之基材薄膜;
  步驟三:將一第二賦型劑、一天然膠體、以及一第二多醣體混合,加熱並持續攪拌直到該第二多醣體完全溶解,成為人工皮膚敷料之殼材;以及
  步驟四:以濾網版加壓塗佈方式將該殼材均勻網印於該基材薄膜之表面,並加熱以除去所有水分,形成一具抗菌止血人工皮膚敷料。
The preparation method of the antibacterial hemostasis artificial skin dressing comprises the following steps:
Step 1: mixing a first excipient, a nano-silver porous composite and a first polysaccharide, heating and stirring until the first polysaccharide is completely dissolved, and becomes a substrate of the artificial skin dressing;
Step 2: uniformly coating the substrate on the plastic soft board by screen coating, and completely removing the water to form a dry and specific thickness substrate film;
Step 3: mixing a second excipient, a natural colloid, and a second polysaccharide, heating and stirring until the second polysaccharide is completely dissolved to become a shell material of the artificial skin dressing; and step 4: The shell material is uniformly screen printed on the surface of the base film by screen coating, and heated to remove all moisture to form an antibacterial hemostatic artificial skin dressing.
如申請專利範圍第1項所述之抗菌止血人工皮膚敷料製備方法,其中該第一賦型劑與該第二賦型劑可分別選自澱粉、甘露醇(mannitol)、乳糖(lactose)、山梨醇(sorbitol)以及聚乙二醇(polyethylene glycol,PEG)所組成之族群。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 1, wherein the first excipient and the second excipient are respectively selected from the group consisting of starch, mannitol, lactose, and sorbus. A group of sorbitol and polyethylene glycol (PEG). 如申請專利範圍第2項所述之抗菌止血人工皮膚敷料製備方法,其中該第一賦型劑與該第二賦型劑係皆選自山梨醇。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 2, wherein the first excipient and the second excipient are both selected from sorbitol. 如申請專利範圍第1項所述之抗菌止血人工皮膚敷料製備方法,其中該第一多醣體係具有羧基(carboxyl)之官能基。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 1, wherein the first polysaccharide system has a carboxyl group functional group. 如申請專利範圍第4項所述之抗菌止血人工皮膚敷料製備方法,其中該第一多醣體係為褐藻酸鈉(alginate)。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 4, wherein the first polysaccharide system is alginate. 如申請專利範圍第1項所述之抗菌止血人工皮膚敷料製備方法,其中該第二多醣體係具有胺基(amine)之官能基。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 1, wherein the second polysaccharide system has an amine functional group. 如申請專利範圍第6項所述之抗菌止血人工皮膚敷料製備方法,其中該第二多醣體係為幾丁聚醣(chitosan)。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 6, wherein the second polysaccharide system is chitosan. 如申請專利範圍第1項所述之抗菌止血人工皮膚敷料製備方法,其中該天然膠體係選自藻膠(align)、膠原蛋白(collagen)、明膠(gelatin)以及果膠(pectin)所組成之族群。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 1, wherein the natural gum system is selected from the group consisting of align, collagen, gelatin, and pectin. Ethnic group. 如申請專利範圍第1項所述之抗菌止血人工皮膚敷料製備方法,其中於該步驟一可進一步加入一保濕劑,該保濕劑係選自山梨醇、玻尿酸原液、植物性甘油(vegetable glycerin)、維他命B5、尿囊素(allantoin)、尿素(urea)以及其等之混合物所組成之族群。The method for preparing an antibacterial hemostatic artificial skin dressing according to the first aspect of the invention, wherein the moisturizing agent is further selected from the group consisting of sorbitol, hyaluronic acid stock solution, vegetable glycerin, A group of vitamin B5, allantoin, urea, and mixtures thereof. 如申請專利範圍第1項所述之抗菌止血人工皮膚敷料製備方法,其中於該步驟一可進一步加入一增稠劑,該增稠劑係選自褐藻酸(alginic acid)、聚麩胺酸(poly(γ-glutamic acid))、聚乙烯醇(polyvinyl alcohol)、幾丁聚醣以及其等之混合物所組成之族群。The method for preparing an antibacterial hemostatic artificial skin dressing according to claim 1, wherein in the step 1, a thickener is further added, which is selected from the group consisting of alginic acid and polyglutamic acid ( A group consisting of poly(γ-glutamic acid), polyvinyl alcohol, chitosan, and the like.
TW101121736A 2012-06-18 2012-06-18 Method for preparing artificial skin dressing with antibacterial and hemostatic functions TWI458470B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101121736A TWI458470B (en) 2012-06-18 2012-06-18 Method for preparing artificial skin dressing with antibacterial and hemostatic functions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101121736A TWI458470B (en) 2012-06-18 2012-06-18 Method for preparing artificial skin dressing with antibacterial and hemostatic functions

Publications (2)

Publication Number Publication Date
TW201400094A true TW201400094A (en) 2014-01-01
TWI458470B TWI458470B (en) 2014-11-01

Family

ID=50344811

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101121736A TWI458470B (en) 2012-06-18 2012-06-18 Method for preparing artificial skin dressing with antibacterial and hemostatic functions

Country Status (1)

Country Link
TW (1) TWI458470B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125800A (en) * 2018-09-15 2019-01-04 深圳市浓华生物电子科技有限公司 A kind of preparation method for patch that moisture film cures the wound patch and moisture film is cured the wound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105588B2 (en) * 2003-10-10 2006-09-12 E. I. Du Pont De Nemours And Company Screen printable hydrogel for medical applications
US7858838B2 (en) * 2006-08-10 2010-12-28 3M Innovative Properties Company Conformable wound dressing
US20110208101A1 (en) * 2010-02-22 2011-08-25 Keller Keith A Compression Dressing
CN101791425B (en) * 2010-03-30 2013-04-10 赵雪林 Antibacterial heal-promoting gel material used for preparing medical wound dressing and preparation method thereof
CN102406957A (en) * 2011-11-04 2012-04-11 无锡中科光远生物材料有限公司 Preparation method of nano silver-containing sodium alginate wound dressing

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125800A (en) * 2018-09-15 2019-01-04 深圳市浓华生物电子科技有限公司 A kind of preparation method for patch that moisture film cures the wound patch and moisture film is cured the wound

Also Published As

Publication number Publication date
TWI458470B (en) 2014-11-01

Similar Documents

Publication Publication Date Title
Rezvani Ghomi et al. Wound dressings: Current advances and future directions
CN103394116B (en) Hydrogel dressing capable of promoting wound healing and preparation method thereof
CN108187120B (en) Anesthesia department medical pain-relieving and bleeding-stopping dressing and preparation method thereof
CN102850598B (en) Alginate-gelatin-carboxymethylcellulose sodium blend membrane, and preparation and application thereof
RU2422133C1 (en) Hydrophylic gel, method of its obtaining (versions), wound covering and based on it bandage means
CN104857552B (en) A kind of hemostatic adhesive bandage and preparation method thereof
JP2022523780A (en) Antibacterial dressings, dressing components, and methods
CN111481735A (en) Medical antibacterial wound-protecting hydrogel dressing and preparation method thereof
EP2916879B1 (en) Wound care device
EP1487506B1 (en) Preparation for wound healing and prevention of bandage adhesion to the wound
Froelich et al. Alginate-based materials loaded with nanoparticles in wound healing
CN103480032B (en) A kind of argentiferous plural gel dressing and preparation method thereof
CN107496973B (en) Chitosan sponge pad band-aid capable of rapidly stopping bleeding and preparation method thereof
TWI458470B (en) Method for preparing artificial skin dressing with antibacterial and hemostatic functions
CN204147173U (en) The compound dressing of a kind of activated carbon fiber
CN106729940B (en) Slow-release long-acting antibacterial silver-loaded dressing and preparation method thereof
Xu et al. Etamsylate loaded oxidized Konjac glucomannan-ε-polylysine injectable hydrogels for rapid hemostasis and wound healing
CN203885716U (en) Self-adhesive alginate applying patch
Sopata et al. Modern methods of conservative treatment of pressure ulcers
CN112870430A (en) Composite gel hemostatic powder based on natural polysaccharide, and preparation method and application thereof
CN202426918U (en) Hydrogel dressing for healing burn wounds
CN207950004U (en) Medical air-permeable strong absorptive Multifunctional plaster
TWI494138B (en) Method for preparing antibacterial non-woven fabric
TWI782850B (en) Three-dimensional network aqueous gel and method for producing the same
CN108144100A (en) A kind of Wound dressing for promoting wound healing and preparation method thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees